PreprintCited by 11Gene expression and cancer classificationProstate Cancer Treatment and ResearchBreast Cancer Treatment Studies

Deep Genomic Signature for early metastasis prediction in prostate cancer

Open access
Sharifi-Noghabi, Hossein, Liu, Yang, Erho, Nicholas, Shrestha, Raunak, Alshalalfa, Mohammed, Davicioni, Elai, Collins, Colin C., Ester, Martin·2018·bioRxiv (Cold Spring Harbor Laboratory)

Abstract

For prostate cancer patients, timing and intensity of therapy are adjusted based on their prognosis. Clinical and pathological factors, and recently, gene expression-based signatures have been shown to predict metastatic prostate cancer. Previous studies used labelled datasets, i.e. those with information on the metastasis outcome, to discover gene signatures to predict metastasis. Due to steady progression of prostate cancer, datasets for this cancer have a limited number of labelled samples but more unlabelled samples. In addition to this issue, the high dimensionality of the gene expression data also poses a significant challenge to train a classifier and predict metastasis accurately. In this study, we aim to boost the prediction accuracy by utilizing both labelled and unlabelled datasets together. We propose Deep Genomic Signature (DGS), a method based on Denoising Auto-Encoders (DAEs) and transfer learning. DGS has the following steps: first, we train a DAE on a large unlabelled gene expression dataset to extract the most salient features of its samples. Then, we train another DAE on a small labelled dataset for a similar purpose. Since the labelled dataset is small, we employ a transfer learning approach and use the parameters learned from the first DAE in the second one. This approach enables us to train a large DAE on a small dataset. After training the second DAE, we obtain the list of genes with high weights by applying a standard deviation filter on the transferred and learned weights. Finally, we train an elastic net logistic regression model on the expression of the selected genes to predict metastasis. Because of the elastic net regularization, some of the selected genes have non-zero coefficients in the classifier which we consider as the DGS gene signature for metastasis. We apply DGS to six labelled and one large unlabelled prostate cancer datasets. Results on five validation datasets indicate that DGS outperforms state-of-the-art gene signatures (obtained from only labelled datasets) in terms of prediction accuracy. Survival analyses demonstrate the potential clinical utility of our gene signature that adds novel prognostic information to the well-established clinical factors and the state-of-the-art gene signatures. Finally, pathway analysis reveals that the DGS gene signature captures the hallmarks of prostate cancer metastasis. These results suggest that our method helps to identify a robust gene signature that may improve patient management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/276055

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Stacked Denoising Autoencoder allows discovery of gene interaction patterns and specific gene expression patterns by extracting features from RNA-Seq data.

    “the dimension of RNA-Seq data can be reduced by techniques, such as Stacked Denoising Autoencoder (SDAE), which allows for the discovery of gene interaction patterns [154] and specific gene expression patterns [155] by extracting features from RNA-Seq data by a supervised learning classification model.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Wanling Xie, Meredith M. Regan, Marc Buyse, Susan Halabi, Philip W. Kantoff, Oliver Sartor, Howard Soule, Noel W. Clarke, Laurence Collette, James J. Dignam, Karim Fizazi, Wendy R. Paruleker, Howard M. Sandler, Matthew R. Sydes, Bertrand Tombal, Scott G. Williams, Christopher J. Sweeney, and on behalf of the ICECaP Working Group. Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer. Journal of Clinical Oncology, 35(27):3097-3104, 2017. PMID: 28796587.
  2. Jason Yosinski, Jeff Clune, Yoshua Bengio, and Hod Lipson. How transferable are features in deep neural networks? In Advances in neural information processing systems, pages 3320-3328, 2014.

Cited by

Sorted by citations

Authors
Sharifi-Noghabi, H., Liu, Y., Erho, N., Shrestha, R., Alshalalfa, M., Davicioni, E., Collins, C. C., & Ester, M.
Affiliations
  • Simon Fraser University (CA)
  • University of British Columbia (CA)
Corresponding author
Ester, Martin
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2018-03-04
OpenAlex
W2790387744
Cited by
11
References
56
Citations by year
2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1
Type
posted content
Language
en
Open access
Licence
cc-by-nd
Locations
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
Funders
  • Cleveland Clinic
  • Johns Hopkins University
  • Thomas Jefferson University
  • Terry Fox Foundation (201012TFF)
  • Canadian Institutes of Health Research (153073, 153073_1)
  • Natural Sciences and Engineering Research Council of Canada
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
prostate cancer, metastasis prediction, gene expression signatures, denoising autoencoder, transfer learning, unlabeled data, elastic net logistic regression, feature selection, prognostic factors, survival analysis, pathway analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review